Evidence map›Paper›PMID 9463343›Full record

ReviewAmerican journal of human genetics1998

Variability in immune response to pathogens: using measles vaccine to probe immunogenetic determinants of response.

G A Poland

Abstract readReview
In one paragraph

Review in American journal of human genetics, 1998. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Toxicogenomic profiles in relation to maternal immunotoxic exposure and immune functionality in newborns.Toxicological sciences : an official journal of the Society of Toxicology · 2012
    Article
  8. Article
  9. Review
  10. Review
  11. Personalized vaccines: the emerging field of vaccinomics.Expert opinion on biological therapy · 2008
    Review
  12. Review
  13. Article
  14. Article
  15. Global survey of genetic variation in CCR5, RANTES, and MIP-1alpha: impact on the epidemiology of the HIV-1 pandemic.Proceedings of the National Academy of Sciences of the United States of America · 2001
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

G A PolandMayo Vaccine Research Group, Clinical Pharmacology Unit, Mayo Clinic and Foundation, Rochester, MN 55905, USA. poland.gregory@mayo.edu

Funding

The Immunogenetics of Measles ImmunityR01AI033144 · NIAID · MAYO CLINIC ROCHESTER · PI POLAND, GREGORY A. · 1993 to 2022
$8.1M
HLA AND VACCINES (BAA)N01AI045240 · NIAID · MAYO CLINIC COLL OF MEDICINE, ROCHESTER · PI POLAND, GREGORY A. · 1994 to 1998
–
FDA HHS HHS FD-5-000-886NIAID NIH HHS N01-AI-45240NIAID NIH HHS R01-2AI-33144
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Major Histocompatibility ComplexMeasles VaccineAntibodies, ViralAntigens, ViralATP-Binding Cassette TransportersATP Binding Cassette Transporter, Subfamily B, Member 2ATP Binding Cassette Transporter, Subfamily B, Member 3HLA AntigensHumansImmunogeneticsMeaslesAntibodies, ViralAntigens, ViralATP-Binding Cassette TransportersATP Binding Cassette Transporter, Subfamily B, Member 2ATP Binding Cassette Transporter, Subfamily B, Member 3HLA AntigensMeasles VaccineTAP1 protein, humanTAP2 protein, human

Identifiers

PMID9463343
PMCPMC1376909

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.